Baader Bank Aktiengesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Baader Bank Aktiengesellschaft's REGN Position: Q2 2026 in Review
Baader Bank Aktiengesellschaft reduced its Regeneron Pharmaceuticals (REGN) stake by 78% in Q2 2026, selling an estimated $3.62M and leaving 1,488 shares worth $928K. The position accounts for 0.07% of the portfolio, ranked #196.
Baader Bank Aktiengesellschaft first reported a position in REGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $7.5M in Q2 2025. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Baader Bank Aktiengesellschaft held 1,488 shares of Regeneron Pharmaceuticals worth $928K as of Q2 2026.
- Baader Bank Aktiengesellschaft sold 5,323 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.62M.
- Regeneron Pharmaceuticals made up 0.07% of Baader Bank Aktiengesellschaft's portfolio in Q2 2026, its #196 holding.
- Baader Bank Aktiengesellschaft first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
- Baader Bank Aktiengesellschaft's Regeneron Pharmaceuticals position peaked at $7.5M in Q2 2025.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.